The results highlight TGR5/BRCA1/Sirt1 signaling as a critical contributor to alleviate BBB damage and as a novel target for brain edema in diseases characterized by BBB damage, such as stroke, inflammatory diseases, and neurodegenerative diseases. The gene discussed is SIRT1; the disease is neurodegenerative disease.